JACLYN JEFFRIES: Open Payments
NPI 1649026683 · LISLE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$547 in 20 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $154 · 2025 $547
Food & beverage: $454Education: $93
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 2 | $115 |
| Lilly USA, LLC | 2 | $54 |
| Novartis Pharmaceuticals Corporation | 2 | $44 |
| Janssen Biotech, Inc. | 2 | $43 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $38 |
| JAZZ PHARMACEUTICALS INC. | 1 | $34 |
| Genentech USA, Inc. | 1 | $33 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $29 |
| AstraZeneca Pharmaceuticals LP | 1 | $29 |
| GlaxoSmithKline, LLC. | 1 | $28 |
Products named: Trodelvy, VERZENIO, Nubeqa, ZEPZELCA, Tecentriq, ALUNBRIG, PLUVICTO, IMFINZI.
Industry payments across IL — which companies pay providers there.
